EXACT SCIENCES CORP Net Change in Cash
EXACT SCIENCES CORP reported Net Change in Cash of $349.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-02-13
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$259.51M.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$257.89M, a 244.18% decline year-over-year.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $178.87M.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$125.69M.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $349.36M.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$3.04M, a 100.83% decline from fiscal 2023.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $366.88M.
- EXACT SCIENCES CORP cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$72.98M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-12-31 | $349.36M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $182.40M 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | $50.46M 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | -$259.51M 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | -$3.04M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | -$15.01M 10-Q · filed 2025-11-03 | |||
| 2024-06-30 | -$73.66M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | -$257.89M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $366.88M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $352.12M 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | $361.87M 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | $178.87M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$72.98M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | -$80.17M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | -$102.05M 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | -$125.69M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$1.18B 10-K · filed 2024-02-21 | |||
| 2021-09-30 | -$1.22B 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$1.13B 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | -$387.49M 10-Q · filed 2022-04-26 | |||
| 2020-12-31 | $1.31B 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $629.44M 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $526.68M 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | $523.81M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $17.10M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $873.90M 10-Q · filed 2020-10-27 | |||
| 2019-06-30 | $44.63M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $124.77M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $82.94M 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $84.21M 10-Q · filed 2019-10-29 | |||
| 2018-06-30 | $148.17M 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $28.57M 10-K · filed 2020-02-21 |